Ferrosan Medical Devices Group A/S - CVR: 43531093

2023,

24.04.2024

Bruttoresultat

Na.

Primær drift

Na.

Årets resultat

Na.

Aktiver

Na.

Kortfristede aktiver

Na.

Egenkapital

Na.

Afkastningsgrad

0 %

Soliditetsgrad

0 %

Likviditetsgrad

0 %

Resultat

24.04.2024

Årsrapport	2023 24.04.2024	2022 31.05.2023
Nettoomsætning
Resultat af primær drift	0	-47.786.000
Indtægter af kapitalandele (tilknyttede og associerede)	0	0
Finansielle indtægter	0	161.000
Finansieringsomkostninger	0	0
Andre finansielle omkostninger	0	-2.102.000
Resultat før skat	0	-49.727.000
Resultat	0	-49.301.000
Forslag til udbytte	0	0

Aktiver

24.04.2024

Årsrapport	2023 24.04.2024	2022 31.05.2023
Kortfristede varebeholdninger	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	0	8.135.000
Likvider	0	1.306.000
Kortfristede aktiver	0	9.441.000
Immaterielle aktiver og goodwill	0	0
Finansielle anlægsaktiver	0	4.679.637.000
Materielle aktiver	0	0
Langfristede aktiver	0	4.679.637.000
Aktiver	0	4.689.078.000

Aktiver

24.04.2024

Passiver

24.04.2024

Årsrapport	2023 24.04.2024	2022 31.05.2023
Forslag til udbytte	0	0
Egenkapital	0	2.835.619.000
Hensatte forpligtelser	0	0
Langfristet gæld til banker	0	1.799.200.000
Anden langfristet gæld		0
Leverandører af varer og tjenesteydelser	0	314.000
Kortfristede forpligtelser	0	32.318.000
Gældsforpligtelser	0	1.853.459.000
Forpligtelser	0	1.853.459.000
Passiver	0	4.689.078.000

Passiver

24.04.2024

Nøgletal

24.04.2024

Årsrapport	2023 24.04.2024	2022 31.05.2023
Afkastningsgrad	Na.	-1,0 %
Dækningsgrad
Resultatgrad	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.
Egenkapitals-forretning	Na.	-1,7 %
Payout-ratio	Na.	Na.
Gældsdæknings-nøgletal	Na.	Na.
Soliditestgrad	Na.	60,5 %
Likviditetsgrad	Na.	29,2 %

Resultat

24.04.2024

Gæld

24.04.2024

Årsrapport

24.04.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 24.04.2024)

Beretning

24.04.2024

Dato for ledelsens godkendelse af årsrapporten:2024-03-20

Ledelsespåtegning:The Board of Directors and the Executive Board have, today, considered and adopted the annual report of Ferrosan Medical Devices Group A/S for the financial year 1 January to 31 December 2023. The Consolidated Financial Statements have been prepared in accordance with IFRS Accounting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act, and the Parent Company Financial Statements have been prepared in accordance with the Danish Financial Statements Act. The Management Review has been prepared in accordance with the Danish Financial Statements Act. In our opinion, the Consolidated Financial Statements and the Parent Company Financial Statements give a true and fair view of the financial position on 31 December 2023 of the Group and the Parent Company and of the results of the Group and Parent Company operations and consolidated cash flows for the financial year 1 January to 31 December 2023. In our opinion, the Management Review includes a true and fair account of the development in the operations and financial circumstances of the Group and the Parent Company, of the results for the year and of the financial position of the Group and the Parent Company as well as a description of the most significant risks and elements of uncertainty facing the Group and the Parent Company. We recommend that the annual report be adopted at the Annual General Meeting.